ALGS vs ALL · rev $3.6M vs P/E 4.9, $56.89B cap
Aligos Therapeutics Inc (ALGS) versus The Allstate Corporation (ALL) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
ALL does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Not investment advice. Open the ALGS and ALL stock pages for the full models.
Not investment advice.